Skip to main content
RCAT
NASDAQ Technology

Shareholders Reject Four Director Nominees and Executive Compensation Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Computer Hardware Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$9.075
Mkt Cap
$1.381B
52W Low
$5.77
52W High
$18.78
52W Position info
57% above low
Off High info
52% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

RCAT sits 57% above its 52-week low of $5.77 on light trading volume (0.3× avg).

Summary

Red Cat Holdings shareholders rejected four director nominees and voted against the executive compensation plan at the annual meeting, indicating widespread dissatisfaction with the company's governance and leadership.


Key Events · Corporate Governance and Compliance · RCAT

  • Four Director Nominees Not Elected

    Four out of five proposed directors (Joseph Freedman, Nicholas Liuzza Jr., Christopher R. Moe, and General (R) Paul E. Funk II) failed to receive sufficient votes for re-election at the Annual Meeting. Only Jeffrey M. Thompson was re-elected.

  • Executive Compensation Plan Rejected

    Shareholders cast a non-binding advisory vote against the compensation of the Named Executive Officers, indicating significant dissatisfaction with executive pay practices.

  • Auditor Appointment Ratified

    KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.


Analysis · RCAT · Technology

The failure to re-elect four out of five director nominees, coupled with the rejection of the executive compensation plan, signals a significant loss of confidence by shareholders in the company's current leadership and governance. This outcome could lead to substantial changes in the board's composition and strategic direction, especially following recent dilutive offerings and ongoing financial challenges such as increased net loss and operating cash burn.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RCAT was trading at $9.08 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $5.77 to $18.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCAT - Latest Insights

RCAT
Sep 18, 2026, 11:50 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $6.84
Real-time Price: $6.39 info
Change: -$0.4505 (-7%) info
Market Cap: $977.372M info
RCAT
Sep 17, 2026, 8:56 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $6.39 info
Change: -$0.7299 (-10%) info
Market Cap: $977.372M info
RCAT
Aug 06, 2026, 5:41 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $8.26
Real-time Price: $6.39 info
Change: -$1.87 (-23%) info
Market Cap: $977.372M info
RCAT
Jul 30, 2026, 7:54 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.39 info
Change: -$0.6599 (-9%) info
Market Cap: $977.372M info
RCAT
Jul 28, 2026, 9:05 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.47
Real-time Price: $6.39 info
Change: -$1.08 (-14%) info
Market Cap: $977.372M info